WHO ICTRP trial
The effect of intravenous magnesium sulfate in the treatment of patients with…
IRCT2014111519962N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2014111519962N1 |
|---|---|
| Public title | The effect of intravenous magnesium sulfate in the treatment of patients with chronic obstructive pulmonary disease |
| Scientific title | The effect of intravenous magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults |
| Primary sponsor | Vice Chanceller for research of Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease with acute exacerbation, unspecified;J44.1 |
| Interventions | Intervention 1: intervention in control group: receive 5 cc of sterile water in 50 cc normal saline. Intervention 2: intervention in case group: infusion of 2.5 grams of Mgso4 in 50 cc normal saline in 20 minutes. |
| Registration date | Feb 4, 2015 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: